Hisamitsu Pharmaceutical Co., Inc. (TYO:4530)
Japan · Delayed Price · Currency is JPY 6,040.00
0.00 (0.00%)
Inactive · Last trade price on May 8, 2026
TYO:4530 Ratios and Metrics
Market cap in millions JPY. Fiscal year is March - February.
Millions JPY. Fiscal year is Mar - Feb.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 7, 2026 | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
| 425,225 | 1,268,571 | 1,076,856 | 1,543,543 | 1,332,371 | 1,310,164 | |
Market Cap Growth | 53.02% | 17.80% | -30.23% | 15.85% | 1.70% | -10.64% |
Enterprise Value | 311,836 | 1,162,944 | 965,701 | 1,421,554 | 1,189,575 | 1,167,876 |
Last Close Price | 6040.00 | 6030.00 | 4163.94 | 3738.10 | 3615.63 | 3384.30 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 7, 2026 | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
PE Ratio | 22.52 | 66.21 | 49.49 | 110.50 | 113.47 | 135.66 |
PS Ratio | 2.61 | 7.78 | 6.90 | 10.89 | 10.38 | 10.90 |
PB Ratio | 1.44 | 4.31 | 3.85 | 5.78 | 5.16 | 5.14 |
P/TBV Ratio | 1.48 | 4.43 | 3.98 | 5.98 | 5.22 | 5.20 |
P/FCF Ratio | 44.84 | 133.77 | 209.59 | 293.23 | 273.70 | 84.04 |
P/OCF Ratio | 24.33 | 72.58 | 57.39 | 84.87 | 104.69 | 68.24 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 7, 2026 | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
EV/Sales Ratio | 1.91 | 7.13 | 6.19 | 10.03 | 9.27 | 9.72 |
EV/EBITDA Ratio | 12.14 | 46.58 | 38.27 | 77.51 | 71.86 | 85.51 |
EV/EBIT Ratio | 16.72 | 64.90 | 51.11 | 107.96 | 102.54 | 125.08 |
EV/FCF Ratio | 32.88 | 122.64 | 187.95 | 270.05 | 244.37 | 74.92 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 7, 2026 | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Debt / EBITDA Ratio | 0.10 | 0.10 | 0.15 | 0.11 | 0.14 | 0.18 |
Debt / FCF Ratio | 0.25 | 0.25 | 0.75 | 0.40 | 0.47 | 0.16 |
Net Debt / Equity Ratio | -0.39 | -0.39 | -0.45 | -0.46 | -0.52 | -0.55 |
Net Debt / EBITDA Ratio | -4.66 | -4.66 | -4.96 | -6.72 | -8.13 | -10.25 |
Net Debt / FCF Ratio | -12.26 | -12.26 | -24.38 | -23.41 | -27.64 | -8.98 |
Asset Turnover | 0.46 | 0.46 | 0.46 | 0.44 | 0.42 | 0.40 |
Inventory Turnover | 2.77 | 2.77 | 2.98 | 3.13 | 3.15 | 2.87 |
Quick Ratio | 3.47 | 3.47 | 3.73 | 3.66 | 4.15 | 5.61 |
Current Ratio | 4.08 | 4.08 | 4.32 | 4.22 | 4.68 | 6.22 |
Return on Equity (ROE) | 6.81% | 6.81% | 8.16% | 5.49% | 4.72% | 3.88% |
Return on Assets (ROA) | 3.15% | 3.15% | 3.52% | 2.56% | 2.35% | 1.94% |
Return on Invested Capital (ROIC) | 8.67% | 8.91% | 9.86% | 7.40% | 7.31% | 6.07% |
Return on Capital Employed (ROCE) | 5.70% | 5.70% | 6.40% | 4.70% | 4.30% | 3.40% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 7, 2026 | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
Earnings Yield | 4.51% | 1.51% | 2.02% | 0.91% | 0.88% | 0.74% |
FCF Yield | 2.23% | 0.75% | 0.48% | 0.34% | 0.36% | 1.19% |
Dividend Yield | 0.74% | 0.19% | 0.52% | 0.57% | 0.58% | 0.62% |
Payout Ratio | 39.63% | 39.63% | 29.96% | 47.09% | 57.22% | 70.81% |
Buyback Yield / Dilution | 3.10% | 3.10% | 4.27% | 3.03% | 2.29% | 0.63% |
Total Shareholder Return | 3.84% | 3.28% | 4.78% | 3.59% | 2.88% | 1.25% |